McKesson EPS - Earnings per Share 2010-2024 | MCK
McKesson annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- McKesson EPS for the quarter ending December 31, 2024 was $6.98, a 56.85% increase year-over-year.
- McKesson EPS for the twelve months ending December 31, 2024 was $21.85, a 1.04% decline year-over-year.
- McKesson 2024 annual EPS was $22.39, a 10.55% decline from 2023.
- McKesson 2023 annual EPS was $25.03, a 246.2% increase from 2022.
- McKesson 2022 annual EPS was $7.23, a 125.58% decline from 2021.
| McKesson Annual EPS |
| 2024 |
$22.39 |
| 2023 |
$25.03 |
| 2022 |
$7.23 |
| 2021 |
$-28.26 |
| 2020 |
$4.95 |
| 2019 |
$0.17 |
| 2018 |
$0.32 |
| 2017 |
$22.73 |
| 2016 |
$9.70 |
| 2015 |
$6.27 |
| 2014 |
$5.41 |
| 2013 |
$5.59 |
| 2012 |
$5.59 |
| 2011 |
$4.57 |
| 2010 |
$4.62 |
| 2009 |
$2.95 |
| McKesson Quarterly EPS |
| 2024-12-31 |
$6.98 |
| 2024-09-30 |
$1.87 |
| 2024-06-30 |
$7.00 |
| 2024-03-31 |
$6.00 |
| 2023-12-31 |
$4.45 |
| 2023-09-30 |
$4.92 |
| 2023-06-30 |
$7.02 |
| 2023-03-31 |
$5.69 |
| 2022-12-31 |
$7.66 |
| 2022-09-30 |
$6.42 |
| 2022-06-30 |
$5.26 |
| 2022-03-31 |
$2.49 |
| 2021-12-31 |
$-0.04 |
| 2021-09-30 |
$1.71 |
| 2021-06-30 |
$3.07 |
| 2021-03-31 |
$4.51 |
| 2020-12-31 |
$-39.03 |
| 2020-09-30 |
$3.54 |
| 2020-06-30 |
$2.72 |
| 2020-03-31 |
$5.67 |
| 2019-12-31 |
$1.03 |
| 2019-09-30 |
$-3.99 |
| 2019-06-30 |
$2.24 |
| 2019-03-31 |
$-4.06 |
| 2018-12-31 |
$2.40 |
| 2018-09-30 |
$2.51 |
| 2018-06-30 |
$-0.68 |
| 2018-03-31 |
$-5.47 |
| 2017-12-31 |
$4.33 |
| 2017-09-30 |
$0.01 |
| 2017-06-30 |
$1.45 |
| 2017-03-31 |
$16.16 |
| 2016-12-31 |
$2.85 |
| 2016-09-30 |
$1.34 |
| 2016-06-30 |
$2.38 |
| 2016-03-31 |
$1.89 |
| 2015-12-31 |
$2.73 |
| 2015-09-30 |
$2.63 |
| 2015-06-30 |
$2.45 |
| 2015-03-31 |
$0.56 |
| 2014-12-31 |
$2.00 |
| 2014-09-30 |
$1.99 |
| 2014-06-30 |
$1.72 |
| 2014-03-31 |
$1.56 |
| 2013-12-31 |
$0.28 |
| 2013-09-30 |
$1.74 |
| 2013-06-30 |
$1.83 |
| 2013-03-31 |
$1.10 |
| 2012-12-31 |
$1.24 |
| 2012-09-30 |
$1.67 |
| 2012-06-30 |
$1.58 |
| 2012-03-31 |
$2.08 |
| 2011-12-31 |
$1.20 |
| 2011-09-30 |
$1.18 |
| 2011-06-30 |
$1.13 |
| 2011-03-31 |
$1.62 |
| 2010-12-31 |
$0.60 |
| 2010-09-30 |
$1.25 |
| 2010-06-30 |
$1.10 |
| 2010-03-31 |
$1.26 |
| 2009-12-31 |
$1.19 |
| 2009-09-30 |
$1.11 |
| 2009-06-30 |
$1.06 |
| 2009-03-31 |
$1.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$84.343B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
